iHuman Reports Sharp Q1 Revenue & Profit Decline, Swings to Operating Loss
IH is trading near its 52-week low of $1.33 (4.5% above the low) on light trading volume (0.1× avg).
Summary
iHuman Inc. reported a significant decline in Q1 2026 revenue and net income, swinging to an operating loss, primarily due to demographic trends and conservative consumer spending in China.
Key Events · Earnings and Guidance · IH
-
Significant Financial Decline
Q1 2026 revenue decreased by 13.2% to RMB182.5 million (US$26.5 million), and net income fell 83% to RMB4.5 million (US$0.7 million) compared to the prior year.
-
Operating Loss Incurred
The company swung from an operating income of RMB21.6 million in Q1 2025 to an operating loss of RMB10.1 million (US$1.5 million) in Q1 2026.
-
User Base Shrinks
Average total Monthly Active Users (MAUs) declined to 23.62 million from 26.51 million, attributed to China's declining newborn population.
-
Acquisition Update & New Leadership
Integration of All Knowledge and Perfect Lingo acquisitions is progressing, with financial details on consideration provided. Teng Li appointed Co-CEO and Congyu Lin as Chief Strategy Officer.
Analysis · IH · Trade & Services
The company's first-quarter results show a substantial deterioration in financial performance, with revenue down over 13% and net income plummeting by 83%, leading to an operating loss. This reinforces concerns about the challenging operating environment in China, particularly the impact of declining birth rates and conservative consumer spending on its education products. While the company highlights strategic investments in AI and provides an update on its recent acquisition and new leadership appointments, these long-term initiatives do not offset the immediate financial weakness. The stock is trading near its 52-week low, and these results are likely to maintain negative pressure.
At the time of this filing, IH was trading at $1.39 on NYSE in the Trade & Services sector, with a market capitalization of approximately $71.6M. The 52-week trading range was $1.33 to $3.60. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.